Literature DB >> 30215772

Growth-restricting effects of siRNA transfections: a largely deterministic combination of off-target binding and hybridization-independent competition.

Neha Daga1,2, Simone Eicher3, Abhilash Kannan1, Alain Casanova3, Shyan H Low3, Saskia Kreibich4, Daniel Andritschke4, Mario Emmenlauer3, Jeremy L Jenkins5, Wolf-Dietrich Hardt4, Urs F Greber1, Christoph Dehio3, Christian von Mering1,2.   

Abstract

Perturbation of gene expression by means of synthetic small interfering RNAs (siRNAs) is a powerful way to uncover gene function. However, siRNA technology suffers from sequence-specific off-target effects and from limitations in knock-down efficiency. In this study, we assess a further problem: unintended effects of siRNA transfections on cellular fitness/proliferation. We show that the nucleotide compositions of siRNAs at specific positions have reproducible growth-restricting effects on mammalian cells in culture. This is likely distinct from hybridization-dependent off-target effects, since each nucleotide residue is seen to be acting independently and additively. The effect is robust and reproducible across different siRNA libraries and also across various cell lines, including human and mouse cells. Analyzing the growth inhibition patterns in correlation to the nucleotide sequence of the siRNAs allowed us to build a predictor that can estimate growth-restricting effects for any arbitrary siRNA sequence. Competition experiments with co-transfected siRNAs further suggest that the growth-restricting effects might be linked to an oversaturation of the cellular miRNA machinery, thus disrupting endogenous miRNA functions at large. We caution that competition between siRNA molecules could complicate the interpretation of double-knockdown or epistasis experiments, and potential interactions with endogenous miRNAs can be a factor when assaying cell growth or viability phenotypes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30215772      PMCID: PMC6182159          DOI: 10.1093/nar/gky798

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

2.  A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity.

Authors:  Li Ding; Maciej Paszkowski-Rogacz; Anja Nitzsche; Mikolaj Michal Slabicki; Anne-Kristin Heninger; Ingrid de Vries; Ralf Kittler; Magno Junqueira; Andrej Shevchenko; Herbert Schulz; Norbert Hubner; Michael Xavier Doss; Agapios Sachinidis; Juergen Hescheler; Roberto Iacone; Konstantinos Anastassiadis; A Francis Stewart; M Teresa Pisabarro; Antonio Caldarelli; Ina Poser; Mirko Theis; Frank Buchholz
Journal:  Cell Stem Cell       Date:  2009-04-02       Impact factor: 24.633

3.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

Authors:  Richard Marcotte; Kevin R Brown; Fernando Suarez; Azin Sayad; Konstantina Karamboulas; Paul M Krzyzanowski; Fabrice Sircoulomb; Mauricio Medrano; Yaroslav Fedyshyn; Judice L Y Koh; Dewald van Dyk; Bodhana Fedyshyn; Marianna Luhova; Glauber C Brito; Franco J Vizeacoumar; Frederick S Vizeacoumar; Alessandro Datti; Dahlia Kasimer; Alla Buzina; Patricia Mero; Christine Misquitta; Josee Normand; Maliha Haider; Troy Ketela; Jeffrey L Wrana; Robert Rottapel; Benjamin G Neel; Jason Moffat
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

4.  Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens.

Authors:  Andrea Franceschini; Roger Meier; Alain Casanova; Saskia Kreibich; Neha Daga; Daniel Andritschke; Sabrina Dilling; Pauli Rämö; Mario Emmenlauer; Andreas Kaufmann; Raquel Conde-Álvarez; Shyan Huey Low; Lucas Pelkmans; Ari Helenius; Wolf-Dietrich Hardt; Christoph Dehio; Christian von Mering
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.

Authors:  E Robert McDonald; Antoine de Weck; Michael R Schlabach; Eric Billy; Konstantinos J Mavrakis; Gregory R Hoffman; Dhiren Belur; Deborah Castelletti; Elizabeth Frias; Kalyani Gampa; Javad Golji; Iris Kao; Li Li; Philippe Megel; Thomas A Perkins; Nadire Ramadan; David A Ruddy; Serena J Silver; Sosathya Sovath; Mark Stump; Odile Weber; Roland Widmer; Jianjun Yu; Kristine Yu; Yingzi Yue; Dorothee Abramowski; Elizabeth Ackley; Rosemary Barrett; Joel Berger; Julie L Bernard; Rebecca Billig; Saskia M Brachmann; Frank Buxton; Roger Caothien; Justina X Caushi; Franklin S Chung; Marta Cortés-Cros; Rosalie S deBeaumont; Clara Delaunay; Aurore Desplat; William Duong; Donald A Dwoske; Richard S Eldridge; Ali Farsidjani; Fei Feng; JiaJia Feng; Daisy Flemming; William Forrester; Giorgio G Galli; Zhenhai Gao; François Gauter; Veronica Gibaja; Kristy Haas; Marc Hattenberger; Tami Hood; Kristen E Hurov; Zainab Jagani; Mathias Jenal; Jennifer A Johnson; Michael D Jones; Avnish Kapoor; Joshua Korn; Jilin Liu; Qiumei Liu; Shumei Liu; Yue Liu; Alice T Loo; Kaitlin J Macchi; Typhaine Martin; Gregory McAllister; Amandine Meyer; Sandra Mollé; Raymond A Pagliarini; Tanushree Phadke; Brian Repko; Tanja Schouwey; Frances Shanahan; Qiong Shen; Christelle Stamm; Christine Stephan; Volker M Stucke; Ralph Tiedt; Malini Varadarajan; Kavitha Venkatesan; Alberto C Vitari; Marco Wallroth; Jan Weiler; Jing Zhang; Craig Mickanin; Vic E Myer; Jeffery A Porter; Albert Lai; Hans Bitter; Emma Lees; Nicholas Keen; Audrey Kauffmann; Frank Stegmeier; Francesco Hofmann; Tobias Schmelzle; William R Sellers
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

Review 6.  RNAi screening comes of age: improved techniques and complementary approaches.

Authors:  Stephanie E Mohr; Jennifer A Smith; Caroline E Shamu; Ralph A Neumüller; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

7.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Authors:  Alexander Karlas; Nikolaus Machuy; Yujin Shin; Klaus-Peter Pleissner; Anita Artarini; Dagmar Heuer; Daniel Becker; Hany Khalil; Lesley A Ogilvie; Simone Hess; André P Mäurer; Elke Müller; Thorsten Wolff; Thomas Rudel; Thomas F Meyer
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

8.  siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.

Authors:  Xiaoyu Lin; Xiaoan Ruan; Mark G Anderson; Jeffrey A McDowell; Paul E Kroeger; Stephen W Fesik; Yu Shen
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

9.  Dose-Response Analysis Using R.

Authors:  Christian Ritz; Florent Baty; Jens C Streibig; Daniel Gerhard
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

10.  Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.

Authors:  Daniela Castanotto; Kumi Sakurai; Robert Lingeman; Haitang Li; Louise Shively; Lars Aagaard; Harris Soifer; Anne Gatignol; Arthur Riggs; John J Rossi
Journal:  Nucleic Acids Res       Date:  2007-07-26       Impact factor: 16.971

View more
  3 in total

Review 1.  Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation.

Authors:  Nayden G Naydenov; Jennifer E Koblinski; Andrei I Ivanov
Journal:  Cell Mol Life Sci       Date:  2020-09-03       Impact factor: 9.261

2.  Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.

Authors:  Dongdong Wang; Nayden G Naydenov; Mikhail G Dozmorov; Jennifer E Koblinski; Andrei I Ivanov
Journal:  Breast Cancer Res       Date:  2020-01-07       Impact factor: 6.466

Review 3.  Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.

Authors:  Peipei Wang; Yue Zhou; Arthur M Richards
Journal:  Theranostics       Date:  2021-08-11       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.